Although some biomarkers, such as CEA, CA199, AFP, CA125, Her-2 and serum Helicobacter pylori antibodies 26, 27, have been reported as the prognostic value in gastric cancer patients, more progress in early diagnosis and treatment is urgently needed. This evidence concerns the gene ERBB2 and gastric cancer.